X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Biomarkers in Medicine

期刊標題檢索 BIOMARK MED 最新評論: Have you had your article reviewed by external reviewers yet? I think ... (2024-11-09)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Biomarkers in Medicine]您好,您是該頁面的第 36894 位訪客。

期刊簡介
期刊名稱Biomarkers in Medicine Biomarkers in Medicine
LetPub Score
6.3
50 ratings
Rate

Reputation
7.6

Influence
4.9

Speed
8.0

期刊簡稱BIOMARK MED
ISSN1752-0363
E-ISSN1752-0371
h-index37
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.800.4810.491
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Biochemistry (medical)
Q234 / 72
Category: Medicine
Subcategory: Drug Discovery
Q395 / 157
Category: Medicine
Subcategory: Clinical Biochemistry
Q375 / 117

自引率 (2023-2024)5.30%自引率趨勢
掲載範囲
Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.

Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.
官方網站http://www.futuremedicine.com/loi/bmm
在線稿件提交http://www.futuremedicine.com/page/submitarticle
開放訪問No
出版商Future Medicine Ltd.
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年2007
每年文章數83每年文章數趨勢
黃金OA百分比10.80%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3127/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1752-0363%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【Biomarkers in Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF CLINICAL INVESTIGATIONH-index: 447

    CiteScore: 24.50
    EMBO Molecular MedicineH-index: 90

    CiteScore: 17.70
    JOURNAL OF BIOMEDICAL SCIENCEH-index: 71

    CiteScore: 18.50
    CLINICAL SCIENCEH-index: 126

    CiteScore: 11.40
    Journal of Translational MedicineH-index: 87

    CiteScore: 10.00
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEH-index: 80

    CiteScore: 12.30
    JOURNAL OF MOLECULAR MEDICINE-JMMH-index: 127

    CiteScore: 9.30
    ARCHIVES OF MEDICAL RESEARCHH-index: 72

    CiteScore: 12.50
    Orphanet Journal of Rare DiseasesH-index: 87

    CiteScore: 6.30
    XENOTRANSPLANTATIONH-index: 56

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    Journal of Translational Medicine258101
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE175296
    JOURNAL OF CLINICAL INVESTIGATION168438
    JOURNAL OF BIOMEDICAL SCIENCE131688
    MEDICAL HYPOTHESES103508
    CLINICAL SCIENCE88295
    MEDICAL SCIENCE MONITOR84783
    Advances in Experimental Medicine and Biology81197
    EMBO Molecular Medicine79566
    EXPERIMENTAL BIOLOGY AND MEDICINE76115
  •  

    Biomarkers in Medicine Biomarkers in Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [Biomarkers in Medicine] 的評論撰寫評論
作者: paper paper中中中!


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-09 21:20:27 評論於
Have you had your article reviewed by external reviewers yet? I think "under consideration" in the previous comments is similar to "under review". Is this journal mandatory open access? It seems like the guidelines mention that if the institution requires open access, it will cost $4000.
(0) 讚! | paper paper中中中!

作者: 李大龙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-04 10:27:23 評論於
After submission, it changed to "Under Consideration" and an editor has been assigned. Is this normal? Are they considering rejecting the submission, like other journals that make a decision within a few days of submission? Also, I had a previous article accepted by this journal. Did they choose to make it non-OA after acceptance, or was it decided at the time of submission? It seems like I never saw any options for payment throughout the submission process.
(0) 讚! | 李大龙

作者: 幽香思怡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 13:23:32 評論於
Please translate the following paragraph into English and Japanese, and use ":" and "
(0) 讚! | 幽香思怡

作者: 中原梓瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-31 16:41:53 評論於
Could you please specify which direction exactly?
(0) 讚! | 中原梓瑶

作者: 风神林帆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-22 18:20:26 評論於
Choose subscription, no need for page charges if you do not select open access
(0) 讚! | 风神林帆

作者: 风神林帆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-09 19:30:18 評論於
First Trial 5 Months
(0) 讚! | 风神林帆

作者: 法慧晴画


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-23 15:26:09 評論於
Are your figures uploaded as a zip file? Or are they uploaded individually as images?
(0) 讚! | 法慧晴画

作者: 东风谷运华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-12 20:25:35 評論於
How much is the usual layout fee?
(0) 讚! | 东风谷运华

作者: 太山晓芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-01 21:34:07 評論於
Has the status changed now?
(0) 讚! | 太山晓芳

作者: 太山晓芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-01 20:41:31 評論於
Has the current situation changed?
(0) 讚! | 太山晓芳

作者: 风神林帆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-02 13:24:46 評論於
Review speed: 6.0
Sharing experience: It has been a few months since submission, and it is still under consideration. I really want to know how long it takes for others to get their first review
(0) 讚! | 风神林帆

作者: 东风谷运华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-24 14:05:11 評論於
Research focus: Medical laboratory experience sharing: May I know the publication fee?
(0) 讚! | 东风谷运华

作者: 菩提怡辰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-30 12:18:14 評論於
Which citation format should I choose for this magazine article? Where can I download the dataset?
(0) 讚! | 菩提怡辰

作者: 狮吼江胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-15 10:47:43 評論於
Review speed: 6.0 | Submission hit rate: 5.0
Emphasized research direction: Oncology; Oncology experience sharing: High rejection rate
(0) 讚! | 狮吼江胜

作者: 擒龙醉丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-18 18:46:03 評論於
Hello, just wanted to check in and see how things are going now
(0) 讚! | 擒龙醉丝

作者: 北陆翰翮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-05 15:41:10 評論於
Hello, are you still there? I am four days late compared to you
(0) 讚! | 北陆翰翮

作者: 北陆翰翮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-05 15:11:52 評論於
It's not an official account, why do you choose such an expensive page fee?
(0) 讚! | 北陆翰翮

作者: Myron Obadiah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-27 11:32:39 評論於
Submission quickly changed to Under Consideration after submission
(0) 讚! | Myron Obadiah

作者: 稻妻迎旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-19 22:25:23 評論於
Hello, may I ask a question? It's been over ten days since I submitted my proposal, and it has always been in the status of just submitted. Based on your past experience, has it been reviewed? Or is it still in the hands of the editor and has not been reviewed yet? Should I send an email to the editor to remind them?
(0) 讚! | 稻妻迎旋

作者: 稻妻迎旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-19 21:16:31 評論於
May I ask when your article was last updated?
How is the status of the article now, has it been accepted?
What are the opinions given by the reviewers?
(0) 讚! | 稻妻迎旋

作者: 稻妻迎旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-19 19:14:04 評論於
Was your article accepted after it was submitted to another magazine?
(0) 讚! | 稻妻迎旋

作者: 珉林喜春


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-03 15:38:26 評論於
Did you choose open access when you submitted? The publication fee is 3500?
(0) 讚! | 珉林喜春

作者: 格拉迪斯桑代克


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-17 20:06:42 評論於
Is it also $3500 if I don't choose open access?
(0) 讚! | 格拉迪斯桑代克

作者: 降龙慧君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-13 17:05:19 評論於
Their submission to the magazine is usually under consideration for about two weeks. If revisions are needed, it will remain under consideration until accepted directly
(0) 讚! | 降龙慧君

作者: 降龙慧君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-10 13:34:01 評論於
Review speed: 2.0 | Submission acceptance rate: 95.0 | Page fees: 3500.0
Emphasized research direction: Oncology; Clinical trial sharing experience: The article is clinically inclined towards esophageal cancer. The review took one month for minor revisions, and it was accepted one month after revisions. Overall, it was relatively fast, with page fees of $3500. One thing to note is that their system does not provide proof immediately after acceptance; an editor's letter is needed, which generally gets a response within two days. When submitting, there's no option to choose first or corresponding authorship, it must be indicated on the title page
(0) 讚! | 降龙慧君

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [Biomarkers in Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*